Home  >  TopNews
Msc_Apr23 Advertisement
you can get e-magazine links on WhatsApp. Click here
Research + Font Resize -
PR_INDIA_Reg_Now_May_2023

VBRI develops programmable nanotheragnostics for early detection and treatment of cancer

Nandita Vijay, Bengaluru
Wednesday, May 29, 2019, 08:00 Hrs  [IST]

In a major research breakthrough in oncology, the Vinoba Bhave Research Institute (VBRI) in Allahabad has developed a programmable nanotheragnostics. This is a combination of diagnostics and therapeutic elements integrated with smart functions at nanoscale which creates a new age medical technology for cancer treatment.
 
The detection of cancer in its early stage of asymptomatic patients before the onset of metastasis is the key challenges in cancer diagnosis. The Institute has a patented technology on sensor and a method for early detection of cancer. No details of investment were shared.
 
“This invention offers early detection of cancer from blood samples. The contemporary research demonstrated smart theranostic approach for early stage tumor sensing, tracking and therapy. For example, the MRI enabled, artificial intelligence (AI)-based anti-neoplastic, spatiotemporal and ROS engineered cancer nanomedicine explores a targeted theragnosis tumor functions without any side effect to the normal cells,” said Dr. Ashutosh Tiwari, managing director and chairman, Vinoba Bhave Research Institute.
 
In a country like India, it is economically not feasible for most to even afford basic radiation therapies, immunotherapy and precision drugs which remain in the realm of science fiction. We saw that rather than investing 99% in curing and 1% in prevention, making people aware of screening and early diagnosis had far more benefits, he added.

The Allahabad-based VBRI has been prioritizing innovation in collaboration with Indian and international universities. Adopting AI, digitization and data and analytics, the researchers have maximised the potential of technology to improve outcomes.

“Our in-house intellectual property rights facility plays an important role in the creation, dissemination and use of new knowledge for further innovations. It helps inventors for appropriate returns on their investments. This enables technology commercialization, field study of the tech solutions, translational research and development,” Dr Tiwari said.
 
Companies are working with a strong motive to build mass healthcare infrastructure for the cancer detection and treatment at the early stage using doorstep technology. Now the four technologies, we are integrating through our devices and applications like IoT (Internet of Things), machine learning, AI and nanotechnology will enable seamless integration to the Indian healthcare system, said Dr. Tiwari.
 
To this end, VBRI’s first priority is to bring all indigenized, affordable and efficacious technology to the forefront of Indian healthcare in the field of cancer management.

 
Eppen_epMotion_May23

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
PharmaLytica
CPhI_China_2023
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |